Home/Filings/4/0001636050-21-000033
4//SEC Filing

Cheruvu Pavan 4

Accession 0001636050-21-000033

CIK 0001636050other

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 7:21 PM ET

Size

5.3 KB

Accession

0001636050-21-000033

Insider Transaction Report

Form 4
Period: 2021-03-23
Cheruvu Pavan
Chief Executive Officer
Transactions
  • Purchase

    Common Stock

    2021-03-23$2.48/sh+100,000$248,180180,426 total
Footnotes (1)
  • [F1]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.46 to $2.50 per share, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchase at each separate price within the range set forth in this footnote.

Issuer

Sio Gene Therapies Inc.

CIK 0001636050

Entity typeother

Related Parties

1
  • filerCIK 0001731741

Filing Metadata

Form type
4
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 7:21 PM ET
Size
5.3 KB